Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer’s disease: pre-clinical and clinical status of emerging therapeutics
- DOI
- 10.1080/14728222.2026.2723488
- Published
- 2026-08-27
- Container
- Expert Opinion on Therapeutic Targets
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14728222.2026.2723488,
title = {Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer’s disease: pre-clinical and clinical status of emerging therapeutics},
author = {Devesh Yaduvanshi and Rishabh Aggarwal and Sameeya A and Mohd Aqil and Mohd Mujeeb and Mohd Akhtar and Abul Kalam Najmi},
year = {2026},
journal = {Expert Opinion on Therapeutic Targets},
doi = {10.1080/14728222.2026.2723488},
url = {https://doi.org/10.1080/14728222.2026.2723488}
}RIS
TY - JOUR TI - Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer’s disease: pre-clinical and clinical status of emerging therapeutics AU - Devesh Yaduvanshi AU - Rishabh Aggarwal AU - Sameeya A AU - Mohd Aqil AU - Mohd Mujeeb AU - Mohd Akhtar AU - Abul Kalam Najmi PY - 2026 JO - Expert Opinion on Therapeutic Targets DO - 10.1080/14728222.2026.2723488 UR - https://doi.org/10.1080/14728222.2026.2723488 ER -
APA
Yaduvanshi, D., Aggarwal, R., A, S., Aqil, M., Mujeeb, M., Akhtar, M., & Najmi, A. K. (2026). Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer’s disease: pre-clinical and clinical status of emerging therapeutics. Expert Opinion on Therapeutic Targets. https://doi.org/10.1080/14728222.2026.2723488
Source records
- crossref · retrieved 2026-09-27T07:05:28.276Z